Ontology list
Cellular componentintracellular membrane-bounded organelle - GO:0043231; cell part - GO:0044464; extracellular space - GO:0005615; nucleus - GO:0005634; membrane-bounded organelle - GO:0043227; nucleoplasm - GO:0005654; intracellular organelle - GO:0043229; nuclear part - GO:0044428; nBAF complex - GO:0071565; euchromatin - GO:0000791; chromosomal part - GO:0044427; protein complex - GO:0043234; heterochromatin - GO:0000792; nbaf complex - GO:0071565; nuclear chromosome part - GO:0044454; baf-type complex - GO:0090544; macromolecular complex - GO:0032991; chromatin - GO:0000785; intracellular organelle part - GO:0044446; extracellular region part - GO:0044421; perichromatin fibrils - GO:0005726; non-membrane-bounded organelle - GO:0043228; neuron part - GO:0097458; swi/snf superfamily-type complex - GO:0070603; organelle part - GO:0044422; npBAF complex - GO:0071564; npbaf complex - GO:0071564; membrane - GO:0016020; nuclear chromatin - GO:0000790; SWI/SNF complex - GO:0016514; nuclear euchromatin - GO:0005719; nucleolus - GO:0005730; intracellular part - GO:0044424; organelle - GO:0043226; intracellular non-membrane-bounded organelle - GO:0043232; swi/snf complex - GO:0016514; cellular_component - GO:0005575;
Molecular functionatp binding - GO:0005524; regulatory region dna binding - GO:0000975; protein binding transcription factor activity - GO:0000988; RNA binding - GO:0003723; small molecule binding - GO:0036094; histone binding - GO:0042393; chromatin dna binding - GO:0031490; RNA polymerase II distal enhancer sequence-specific DNA binding - GO:0000980; Tat protein binding - GO:0030957; protein binding - GO:0005515; transcription regulatory region sequence-specific dna binding - GO:0000976; enhancer binding - GO:0035326; transcription cofactor activity - GO:0003712; transcription corepressor activity - GO:0003714; nucleoside binding - GO:0001882; enhancer sequence-specific dna binding - GO:0001158; DNA polymerase binding - GO:0070182; carbohydrate derivative binding - GO:0097367; anion binding - GO:0043168; sequence-specific dna binding - GO:0043565; nucleosome binding - GO:0031491; rna polymerase ii distal enhancer sequence-specific dna binding - GO:0000980; chromatin binding - GO:0003682; rna polymerase ii core promoter proximal region sequence-specific dna binding - GO:0000978; rna polymerase ii regulatory region dna binding - GO:0001012; RNA polymerase I CORE element sequence-specific DNA binding - GO:0001164; hydrolase activity - GO:0016787; nucleic acid binding - GO:0003676; transcription factor binding - GO:0008134; rna polymerase ii transcription factor binding transcription factor activity - GO:0001076; rna polymerase ii transcription factor binding transcription factor activity involved in positive regulation of transcription - GO:0001190; core promoter proximal region sequence-specific dna binding - GO:0000987; steroid hormone receptor binding - GO:0035258; androgen receptor binding - GO:0050681; purine ribonucleoside binding - GO:0032550; molecular_function - GO:0003674; pyrophosphatase activity - GO:0016462; ribonucleotide binding - GO:0032553; rna polymerase ii regulatory region sequence-specific dna binding - GO:0000977; protein complex binding - GO:0032403; protein N-terminus binding - GO:0047485; hydrolase activity; acting on acid anhydrides - GO:0016817; p53 binding - GO:0002039; purine nucleoside binding - GO:0001883; hormone receptor binding - GO:0051427; protein n-terminus binding - GO:0047485; purine ribonucleoside triphosphate binding - GO:0035639; ion binding - GO:0043167; purine nucleotide binding - GO:0017076; organic cyclic compound binding - GO:0097159; purine ribonucleotide binding - GO:0032555; dna polymerase binding - GO:0070182; RNA polymerase II core promoter proximal region sequence-specific DNA binding - GO:0000978; binding - GO:0005488; hydrolase activity; acting on acid anhydrides; in phosphorus-containing anhydrides - GO:0016818; ribonucleoside binding - GO:0032549; nucleotide binding - GO:0000166; nucleosomal dna binding - GO:0031492; tat protein binding - GO:0030957; receptor binding - GO:0005102; adenyl nucleotide binding - GO:0030554; DNA-dependent ATPase activity - GO:0008094; core promoter proximal region dna binding - GO:0001159; heterocyclic compound binding - GO:1901363; atpase activity - GO:0016887; enzyme binding - GO:0019899; rna polymerase ii transcription cofactor activity - GO:0001104; dna-dependent atpase activity - GO:0008094; nucleosomal DNA binding - GO:0031492; helicase activity - GO:0004386; rna polymerase ii transcription coactivator activity - GO:0001105; regulatory region nucleic acid binding - GO:0001067; transcription factor binding transcription factor activity - GO:0000989; dna binding - GO:0003677; transcription regulatory region dna binding - GO:0044212; nuclear hormone receptor binding - GO:0035257; transcription coactivator activity - GO:0003713; lysine-acetylated histone binding - GO:0070577; adenyl ribonucleotide binding - GO:0032559; macromolecular complex binding - GO:0044877; structure-specific dna binding - GO:0043566; ATP binding - GO:0005524; DNA binding - GO:0003677; nucleoside phosphate binding - GO:1901265; catalytic activity - GO:0003824; nucleoside-triphosphatase activity - GO:0017111; atpase activity; coupled - GO:0042623;
Biological processsingle-organism cellular process - GO:0044763; negative regulation of cellular metabolic process - GO:0031324; liver development - GO:0001889; nucleobase-containing compound biosynthetic process - GO:0034654; regulation of signal transduction - GO:0009966; regulation of transcription from RNA polymerase II promoter - GO:0006357; negative regulation of macromolecule metabolic process - GO:0010605; regulation of cellular macromolecule biosynthetic process - GO:2000112; erythrocyte differentiation - GO:0030218; embryonic appendage morphogenesis - GO:0035113; interleukin-7-mediated signaling pathway - GO:0038111; methylation-dependent chromatin silencing - GO:0006346; morphogenesis of an epithelium - GO:0002009; cellular biosynthetic process - GO:0044249; embryonic limb morphogenesis - GO:0030326; negative regulation of rna biosynthetic process - GO:1902679; biological regulation - GO:0065007; vasculogenesis - GO:0001570; negative regulation of cell growth - GO:0030308; interspecies interaction between organisms - GO:0044419; positive regulation of multi-organism process - GO:0043902; lens fiber cell development - GO:0070307; positive regulation of sequence-specific DNA binding transcription factor activity - GO:0051091; positive regulation of nucleobase-containing compound metabolic process - GO:0045935; peptidyl-amino acid modification - GO:0018193; regulation of androgen receptor signaling pathway - GO:0060765; negative regulation of intracellular steroid hormone receptor signaling pathway - GO:0033144; rna metabolic process - GO:0016070; histone h3 acetylation - GO:0043966; limb morphogenesis - GO:0035108; regulation of molecular function - GO:0065009; interaction with symbiont - GO:0051702; RNA polymerase I transcriptional preinitiation complex assembly - GO:0001188; cellular developmental process - GO:0048869; positive regulation of viral process - GO:0048524; protein-dna complex subunit organization - GO:0071824; modulation of transcription in other organism involved in symbiotic interaction - GO:0052312; negative regulation of growth - GO:0045926; positive regulation of metabolic process - GO:0009893; dna methylation or demethylation - GO:0044728; single-organism metabolic process - GO:0044710; regulation of symbiosis; encompassing mutualism through parasitism - GO:0043903; chromatin silencing - GO:0006342; single-multicellular organism process - GO:0044707; negative regulation of cell cycle - GO:0045786; cellular nitrogen compound biosynthetic process - GO:0044271; negative regulation of transcription from RNA polymerase II promoter - GO:0000122; regulation of biosynthetic process - GO:0009889; epidermal cell differentiation - GO:0009913; biosynthetic process - GO:0009058; positive regulation of nucleic acid-templated transcription - GO:1903508; positive regulation of binding - GO:0051099; negative regulation of signaling - GO:0023057; covalent chromatin modification - GO:0016569; regulation of cellular metabolic process - GO:0031323; regulation of binding - GO:0051098; negative regulation of biological process - GO:0048519; cellular protein metabolic process - GO:0044267; regulation of cell cycle phase transition - GO:1901987; negative regulation of metabolic process - GO:0009892; anatomical structure formation involved in morphogenesis - GO:0048646; regulation of gene expression; epigenetic - GO:0040029; cellular component organization - GO:0016043; protein modification process - GO:0036211; appendage morphogenesis - GO:0035107; nervous system development - GO:0007399; atp-dependent chromatin remodeling - GO:0043044; biological_process - GO:0008150; macromolecular complex subunit organization - GO:0043933; positive regulation of Wnt signaling pathway - GO:0030177; negative regulation of cell cycle process - GO:0010948; positive regulation of cellular biosynthetic process - GO:0031328; organism emergence from protective structure - GO:0071684; negative regulation of transcription during mitosis - GO:0007068; positive regulation of viral transcription - GO:0050434; positive regulation of macromolecule biosynthetic process - GO:0010557; positive regulation of nitrogen compound metabolic process - GO:0051173; negative regulation of transcription from rna polymerase ii promoter during mitosis - GO:0007070; nucleosome disassembly - GO:0006337; cellular nitrogen compound metabolic process - GO:0034641; positive regulation of cellular metabolic process - GO:0031325; protein acetylation - GO:0006473; negative regulation of rna metabolic process - GO:0051253; positive regulation of rna biosynthetic process - GO:1902680; regulation of intracellular steroid hormone receptor signaling pathway - GO:0033143; regulation of dna binding - GO:0051101; macromolecular complex disassembly - GO:0032984; positive regulation of dna binding - GO:0043388; negative regulation of nucleobase-containing compound metabolic process - GO:0045934; single-organism process - GO:0044699; hindlimb morphogenesis - GO:0035137; dna metabolic process - GO:0006259; positive regulation of macromolecule metabolic process - GO:0010604; negative regulation of cellular macromolecule biosynthetic process - GO:2000113; regulation of mitotic cell cycle phase transition - GO:1901990; positive regulation of transcription; DNA-templated - GO:0045893; negative regulation of macromolecule biosynthetic process - GO:0010558; single-organism organelle organization - GO:1902589; regulation of developmental process - GO:0050793; macromolecule metabolic process - GO:0043170; regulation of cell cycle - GO:0051726; definitive erythrocyte differentiation - GO:0060318; positive regulation of cell communication - GO:0010647; dna alkylation - GO:0006305; vascular smooth muscle cell differentiation - GO:0035886; positive regulation of pri-mirna transcription from rna polymerase ii promoter - GO:1902895; regulation of viral process - GO:0050792; nucleobase-containing compound metabolic process - GO:0006139; regulation of wnt signaling pathway - GO:0030111; heterocycle biosynthetic process - GO:0018130; regulation of primary metabolic process - GO:0080090; regulation of g1/s transition of mitotic cell cycle - GO:2000045; positive regulation of biosynthetic process - GO:0009891; blastocyst growth - GO:0001832; positive regulation of response to stimulus - GO:0048584; heart trabecula formation - GO:0060347; regulation of cell cycle process - GO:0010564; regulation of cellular biosynthetic process - GO:0031326; dna methylation on cytosine within a cg sequence - GO:0010424; protein complex disassembly - GO:0043241; macromolecule methylation - GO:0043414; regulation of nitrogen compound metabolic process - GO:0051171; dna methylation on cytosine - GO:0032776; nucleosome organization - GO:0034728; negative regulation of cellular process - GO:0048523; regulation of growth - GO:0040008; growth - GO:0040007; stem cell maintenance - GO:0019827; extracellular structure organization - GO:0043062; gland development - GO:0048732; regulation of transcription from rna polymerase ii promoter; mitotic - GO:0046021; cellular component disassembly - GO:0022411; regulation of metabolic process - GO:0019222; myeloid cell differentiation - GO:0030099; macromolecule biosynthetic process - GO:0009059; tissue morphogenesis - GO:0048729; ATP-dependent chromatin remodeling - GO:0043044; anatomical structure development - GO:0048856; muscle cell differentiation - GO:0042692; chromatin modification - GO:0016568; regulation of transcription during mitosis - GO:0045896; positive regulation of glucose mediated signaling pathway - GO:1902661; regulation of biological quality - GO:0065008; multicellular organismal process - GO:0032501; cellular macromolecule biosynthetic process - GO:0034645; cellular macromolecule metabolic process - GO:0044260; negative regulation of transcription; DNA-templated - GO:0045892; regulation of cellular component organization - GO:0051128; epidermis morphogenesis - GO:0048730; extracellular matrix organization - GO:0030198; modification of morphology or physiology of other organism - GO:0035821; peptidyl-lysine modification - GO:0018205; developmental process - GO:0032502; cell morphogenesis - GO:0000902; internal peptidyl-lysine acetylation - GO:0018393; negative regulation of signal transduction - GO:0009968; peptidyl-lysine acetylation - GO:0018394; anatomical structure morphogenesis - GO:0009653; negative regulation of gene expression - GO:0010629; modification by host of symbiont morphology or physiology - GO:0051851; organic cyclic compound metabolic process - GO:1901360; regulation of mitotic cell cycle - GO:0007346; regulation of viral transcription - GO:0046782; heterocycle metabolic process - GO:0046483; beta-catenin-TCF complex assembly - GO:1904837; regulation of biological process - GO:0050789; protein metabolic process - GO:0019538; developmental growth - GO:0048589; blastocyst hatching - GO:0001835; negative regulation of nucleic acid-templated transcription - GO:1903507; dna methylation - GO:0006306; modification of morphology or physiology of other organism involved in symbiotic interaction - GO:0051817; regulation of nucleobase-containing compound metabolic process - GO:0019219; cellular component morphogenesis - GO:0032989; gene silencing - GO:0016458; organic substance metabolic process - GO:0071704; forebrain development - GO:0030900; epithelial cell development - GO:0002064; hindbrain development - GO:0030902; negative regulation of g1/s transition of mitotic cell cycle - GO:2000134; modulation by host of viral transcription - GO:0043921; regulation of transcription; dna-templated - GO:0006355; positive regulation of transcription from rna polymerase ii promoter - GO:0045944; regulation of rna biosynthetic process - GO:2001141; positive regulation by host of viral transcription - GO:0043923; positive regulation of rna metabolic process - GO:0051254; cellular aromatic compound metabolic process - GO:0006725; organic substance biosynthetic process - GO:1901576; transcription; dna-templated - GO:0006351; regulation of pri-mirna transcription from rna polymerase ii promoter - GO:1902893; regulation of sequence-specific dna binding transcription factor activity - GO:0051090; trabecula formation - GO:0060343; negative regulation of androgen receptor signaling pathway - GO:0060766; negative regulation of biosynthetic process - GO:0009890; single-organism developmental process - GO:0044767; negative regulation of nitrogen compound metabolic process - GO:0051172; positive regulation of wnt signaling pathway - GO:0030177; cellular protein modification process - GO:0006464; positive regulation of molecular function - GO:0044093; negative regulation of cell differentiation - GO:0045596; cellular process - GO:0009987; negative regulation of cell communication - GO:0010648; keratinocyte differentiation - GO:0030216; chromatin remodeling - GO:0006338; positive regulation of biological process - GO:0048518; multi-organism process - GO:0051704; negative regulation of cell cycle g1/s phase transition - GO:1902807; positive regulation of pri-miRNA transcription from RNA polymerase II promoter - GO:1902895; histone acetylation - GO:0016573; hatching - GO:0035188; epithelial cell differentiation - GO:0030855; protein acylation - GO:0043543; regulation of cell communication - GO:0010646; regulation of cell growth - GO:0001558; primary metabolic process - GO:0044238; regulation of nucleic acid-templated transcription - GO:1903506; neural retina development - GO:0003407; nitrogen compound metabolic process - GO:0006807; rna biosynthetic process - GO:0032774; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter - GO:1901838; negative regulation of mitotic cell cycle phase transition - GO:1901991; regulation of multi-organism process - GO:0043900; embryonic hindlimb morphogenesis - GO:0035116; cell development - GO:0048468; glial cell fate determination - GO:0007403; regulation of signaling - GO:0023051; protein complex subunit organization - GO:0071822; dna modification - GO:0006304; positive regulation of transcription from RNA polymerase II promoter - GO:0045944; negative regulation of response to stimulus - GO:0048585; regulation of rna metabolic process - GO:0051252; smooth muscle cell differentiation - GO:0051145; cell differentiation - GO:0030154; organelle organization - GO:0006996; organic cyclic compound biosynthetic process - GO:1901362; regulation of gene expression - GO:0010468; chromatin organization - GO:0006325; negative regulation of developmental process - GO:0051093; cell fate determination - GO:0001709; histone modification - GO:0016570; negative regulation of cellular biosynthetic process - GO:0031327; regulation of cell differentiation - GO:0045595; regulation of transcription from rna polymerase ii promoter - GO:0006357; organ development - GO:0048513; protein-dna complex disassembly - GO:0032986; nucleic acid-templated transcription - GO:0097659; methylation - GO:0032259; embryonic organ morphogenesis - GO:0048562; metabolic process - GO:0008152; nucleic acid metabolic process - GO:0090304; positive regulation of sequence-specific dna binding transcription factor activity - GO:0051091; aromatic compound biosynthetic process - GO:0019438; organ morphogenesis - GO:0009887; positive regulation of signal transduction - GO:0009967; negative regulation of transcription; dna-templated - GO:0045892; regulation of macromolecule metabolic process - GO:0060255; macromolecule modification - GO:0043412; negative regulation of mitotic cell cycle - GO:0045930; regulation of response to stimulus - GO:0048583; positive regulation of cellular process - GO:0048522; aortic smooth muscle cell differentiation - GO:0035887; negative regulation of transcription from rna polymerase ii promoter - GO:0000122; internal protein amino acid acetylation - GO:0006475; modulation by host of symbiont transcription - GO:0052472; cellular component organization or biogenesis - GO:0071840; embryonic morphogenesis - GO:0048598; positive regulation of gene expression - GO:0010628; positive regulation of transcription; dna-templated - GO:0045893; regulation of macromolecule biosynthetic process - GO:0010556; cellular metabolic process - GO:0044237; regulation of cellular process - GO:0050794; regulation of cell cycle g1/s phase transition - GO:1902806; negative regulation of gene expression; epigenetic - GO:0045814; positive regulation of signaling - GO:0023056; negative regulation of cell cycle phase transition - GO:1901988;